GlassScriptPhysician profile
Andrew D Cooper
NPI 1477547164
$22,284.57
in general payments reported to CMS, 2019-2025
15 companies · $99.13 in 2025
The $99.13 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,985 · 2020: $11K · 2021: $2,943 · 2022: $3,646 · 2023: $209 · 2024: $114 · 2025: $99.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $11,414.24 | 2019-2020 | |
| Active Medical, LLC | $5,172.62 | 2019-2024 | |
| Elevate Surgical Co | $2,424.13 | 2022 | |
| Arthrex, INC. | $2,019.00 | 2019-2021 | |
| Stryker Corporation | $496.42 | 2019 | |
| Heron Therapeutics, INC. | $173.34 | 2024-2025 | Zynrelef |
| Smith+Nephew, INC. | $166.90 | 2019 | |
| Orthofix Medical, INC. | $122.42 | 2023 | Physio-Stim |
| Medtronic, INC. | $86.64 | 2023 | Ta |
| Allergan, INC. | $51.16 | 2019 | |
| Depuy Synthes Sales INC. | $50.61 | 2021-2022 | |
| Haemonetics Corporation | $40.12 | 2020-2021 | |
| Lilly USA, LLC | $26.21 | 2021 | |
| Ferring Pharmaceuticals INC. | $25.55 | 2019 | |
| Bioventus LLC | $15.21 | 2025 | Xcell |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.